Jeffrey C. Theiss

1.9k total citations
63 papers, 1.4k citations indexed

About

Jeffrey C. Theiss is a scholar working on Cancer Research, Molecular Biology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Jeffrey C. Theiss has authored 63 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Cancer Research, 23 papers in Molecular Biology and 15 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Jeffrey C. Theiss's work include Carcinogens and Genotoxicity Assessment (33 papers), DNA Repair Mechanisms (14 papers) and Safe Handling of Antineoplastic Drugs (12 papers). Jeffrey C. Theiss is often cited by papers focused on Carcinogens and Genotoxicity Assessment (33 papers), DNA Repair Mechanisms (14 papers) and Safe Handling of Antineoplastic Drugs (12 papers). Jeffrey C. Theiss collaborates with scholars based in United States, Japan and Bulgaria. Jeffrey C. Theiss's co-authors include G. Krishna, Thomas S. Matney, Michael B. Shimkin, Thomas H. Connor, Roger W. Anderson, David Monteith, Jana L. Laidlaw, Gary D. Stoner, Victor Ciaravino and Elizabeth K. Weisburger and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Journal of Medicinal Chemistry and Biochemical Pharmacology.

In The Last Decade

Jeffrey C. Theiss

63 papers receiving 1.3k citations

Peers

Countries citing papers authored by Jeffrey C. Theiss

Since Specialization

Citations

This map shows the geographic impact of Jeffrey C. Theiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey C. Theiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey C. Theiss more than expected).

Fields of papers citing papers by Jeffrey C. Theiss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey C. Theiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey C. Theiss. The network helps show where Jeffrey C. Theiss may publish in the future.

Co-authorship network of co-authors of Jeffrey C. Theiss

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey C. Theiss. A scholar is included among the top collaborators of Jeffrey C. Theiss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey C. Theiss. Jeffrey C. Theiss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Principles and practices of integrating genotoxicity evaluation into routine toxicology studies: A pharmaceutical industry perspective 1998 ·Environmental and Molecular Mutagenesis ·G. Krishna, (unknown), Jeffrey C. Theiss	24
2	Use of acridine orange in: flow cytometric evaluation of erythropoietic cytotoxicity 1998 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Kay A. Criswell, G. Krishna, David Zielinski, (unknown), Jeffrey C. Theiss, Paul Juneau, M. R. Bleavins	19
3	Preclinical toxicology studies with the angiotensin-converting enzyme inhibitor quinapril hydrochloride (accupril). 1996 ·The Journal of Toxicological Sciences ·Edward J. McGuire, (unknown), (unknown), James R. Herman, (unknown), Jeffrey C. Theiss, Felix A. de la Iglesia	4
4	Genotoxicity evaluation of selenium sulfide in in vivo and in vivo/in vitro micronucleus and chromosome aberration assays 1996 ·Mutation Research/Genetic Toxicology ·(unknown), (unknown), G. Krishna, Jeffrey C. Theiss	14
5	In vitro induction of micronuclei and chromosome aberrations by quinolones: possible mechanisms 1996 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·(unknown), (unknown), (unknown), (unknown), Jeffrey C. Theiss	21
6	Cytotoxicity Study of Tacrine, Structurally and Pharmacologically Related Compounds Using Rat Hepatocytes 1996 ·Drug and Chemical Toxicology ·David Monteith, Mark R. Emmerling, James E. Garvin, Jeffrey C. Theiss	12
7	The genotoxicity profile of atorvastatin, a new drug in the treatment of hypercholesterolemia 1995 ·Mutation Research/Genetic Toxicology ·Victor Ciaravino, (unknown), (unknown), (unknown), Jeffrey C. Theiss	25
8	Use of cyclophosphamide as a positive control in dominant lethal and micronucleus assays 1995 ·Mutation Research/Environmental Mutagenesis and Related Subjects ·G. Krishna, Judith A. Petrere, Jane Anderson, Jeffrey C. Theiss	34
9	Concurrent analysis of cytogenetic damage in vivo: A multiple endpoint‐multiple tissue approach 1995 ·Environmental and Molecular Mutagenesis ·G. Krishna, Jeffrey C. Theiss	22
10	An in vivo/in vitro method for assessing micronucleus and chromosome aberration induction in rat bone marrow and spleen 2. Studies with chlorambucil and mitomycin C 1995 ·Mutation Research/Environmental Mutagenesis and Related Subjects ·(unknown), (unknown), G. Krishna, Jeffrey C. Theiss	10
11	Mammalian cell gene mutation assays working group report 1994 ·Mutation Research/Environmental Mutagenesis and Related Subjects ·C.S. Aaron, George Bölcsföldi, Hansruedi Glatt, Martha M. Moore, (unknown), Leon F. Stankowski, Jeffrey C. Theiss, Elizabeth Thompson	50
12	High capacity in vitro micronucleus assay for assessment of chromosome damage: results with quinolone / naphthyridone antibacterials 1993 ·Mutation Research/Genetic Toxicology ·Victor Ciaravino, Mark J. Suto, Jeffrey C. Theiss	22
13	Simultaneous evaluation of clastogenicity, aneugenicity and toxicity in the mouse micronucleus assay using immunofluorescence 1992 ·Mutation Research Letters ·G. Krishna, (unknown), Jeffrey C. Theiss	35
14	Cytogenetic analysis of pulmonary lavage and bone marrow cells of rats after repeated formaldehyde inhalation 1992 ·Journal of Applied Toxicology ·Cham E. Dallas, Michael J. Scott, Jonathan B. Ward, Jeffrey C. Theiss	33
15	Genotoxicity assessment of pirmenol, a new antiarrhythmic drug 1992 ·Mutation Research/Genetic Toxicology ·Victor Ciaravino, (unknown), G. Krishna, David Monteith, Jeffrey C. Theiss	2
16	Dimethylnitrosamine-induced micronucleus formation in mouse bone marrow and spleen 1990 ·Mutation Research/Genetic Toxicology ·G. Krishna, (unknown), Jeffrey C. Theiss	19
17	Use of the cytokinesis-block method for the analysis of munuclei in V79 Chinese hamster lung cells: results with mitomycin C and cyclophosphamide 1989 ·Mutation Research/Genetic Toxicology ·G. Krishna, (unknown), Jeffrey C. Theiss	60
18	Stability and inactivation of mutagenic drugs and their metabolites in the urine of patients administered antineoplastic therapy 1987 ·Environmental and Molecular Mutagenesis ·David Monteith, Thomas H. Connor, John A. Benvenuto, Edward J. Fairchild, Jeffrey C. Theiss	15
19	Inhibiting effect of caffeine on spontaneous and urethan-induced lung tumors in strain A mice. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Jeffrey C. Theiss, Michael B. Shimkin	36
20	Test for carcinogenicity of organic contaminants of United States drinking waters by pulmonary tumor response in strain A mice. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Jeffrey C. Theiss, Gary D. Stoner, Michael B. Shimkin, Elizabeth K. Weisburger	69

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact